A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
FINE FOODS & PHARMACEUTICALS NT operates in the Packaged Foods industry, Consumer Defensive sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 263M | 263M | 273M | 218M | 230M |
| Net Income | 0 | - | -3.8M | -10M | -1.7M |
| EPS | $34.57 | $34.57 | $-0.15 | $-0.39 | $-0.07 |
| Free Cash Flow | 13M | 13M | 447K | -12M | -24M |
| ROIC | 0.0% | 6.5% | 0.4% | -0.4% | 2.2% |
| Gross Margin | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.40 | 0.51 | 0.62 | 0.31 |
| Dividends/Share | $0.00 | - | $0.11 | $0.16 | $0.16 |
| Operating Income | 16M | 16M | 1.2M | -1.1M | 5.9M |
| Operating Margin | 6.0% | 6.0% | 0.4% | -0.5% | 2.6% |
| ROE | 0.0% | - | -2.7% | -6.4% | -1.0% |
| Shares Outstanding | 0M | - | 25M | 26M | 24M |
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 230M | 218M | 273M | 263M | 263M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 5.9M | -1.1M | 1.2M | 16M | 16M |
| Op. Margin | 2.6% | -0.5% | 0.4% | 6.0% | 6.0% |
| Net Income | -1.7M | -10M | -3.8M | N/A | 0 |
| Net Margin | -0.7% | -4.6% | -1.4% | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | 2.2% | -0.4% | 0.4% | 6.5% | 0.0% |
| ROE | -1.0% | -6.4% | -2.7% | N/A | 0.0% |
| ROA | -0.5% | -3.0% | -1.3% | N/A | 0.0% |
| Cash Flow | |||||
| Op. Cash Flow | -6.9M | 3.9M | 20M | 50M | 50M |
| Free Cash Flow | -24M | -12M | 447K | 13M | 13M |
| Owner Earnings | -24M | -13M | -2.9M | 32M | 32M |
| CapEx | 18M | 16M | 20M | 37M | 37M |
| Maint. CapEx | 17M | 17M | 23M | 17M | 17M |
| Growth CapEx | 380K | 0 | 0 | 20M | 20M |
| D&A | 17M | 17M | 23M | 17M | 17M |
| CapEx/OCF | N/A | 407.4% | 97.8% | 73.9% | 73.9% |
| Capital Allocation | |||||
| Dividends Paid | 3.8M | 4.1M | 2.7M | 3.2M | 3.2M |
| Dividend Yield | 1.0% | 1.6% | 1.2% | N/A | N/A |
| Share Buybacks | 8.5M | 917K | 370K | 128K | 128K |
| Buyback Yield | 2.1% | 0.4% | 0.2% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 15M | 65M | 59M | 13M | 13M |
| Balance Sheet | |||||
| Net Debt | 34M | 76M | 50M | 37M | -21M |
| Cash & Equiv. | 20M | 11M | 21M | 21M | 21M |
| Long-Term Debt | N/A | N/A | 11M | 38M | 38M |
| Debt/Equity | 0.31 | 0.62 | 0.51 | 0.40 | 0.00 |
| Interest Coverage | 6.6 | -0.5 | 0.2 | 4.2 | 4.2 |
| Equity | 174M | 140M | 138M | 143M | 143M |
| Total Assets | 357M | 316M | 262M | 262M | 262M |
| Total Liabilities | 184M | 175M | 124M | 119M | 119M |
| Intangibles | N/A | N/A | 1.8M | 1.7M | 1.7M |
| Retained Earnings | 0 | 24K | 25K | 5.1M | 5.1M |
| Working Capital | 73M | 85M | 11M | 28M | 28M |
| Current Assets | 202M | 173M | 121M | 104M | 104M |
| Current Liabilities | 129M | 88M | 110M | 76M | 76M |
| Per Share Data | |||||
| EPS | -0.07 | -0.39 | -0.15 | 34.57 | 34.57 |
| Owner EPS | -1.01 | -0.52 | -0.12 | N/A | N/A |
| Book Value | 7.31 | 5.47 | 5.48 | N/A | 0.00 |
| Cash Flow/Share | -0.29 | 0.15 | 0.80 | N/A | 0.00 |
| Dividends/Share | 0.16 | 0.16 | 0.11 | N/A | 0.00 |
| Shares Out. | 23.8M | 25.7M | 25.2M | N/A | 0.0M |
| Valuation | |||||
| P/E Ratio | -241.5 | -22.8 | -61.1 | 0.2 | 0.2 |
| P/FCF | N/A | N/A | 522.5 | N/A | N/A |
| EV/EBIT | 74.2 | N/A | 245.0 | 2.3 | -1.3 |
| Price/Book | 2.3 | 1.6 | 1.7 | N/A | N/A |
| Price/Sales | 1.8 | 1.0 | 0.9 | N/A | N/A |
| FCF Yield | -6.0% | -5.2% | 0.2% | N/A | N/A |
| Market Cap | 407M | 228M | 234M | 0 | 0 |
| Avg. Price | 16.65 | 10.07 | 8.84 | 9.17 | 8.50 |
| Year-End Price | 17.10 | 8.89 | 9.29 | 7.68 | 8.50 |
FINE FOODS & PHARMACEUTICALS NT passes 2 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 2.2%.
FINE FOODS & PHARMACEUTICALS NT (FF-MI) has a 5-year average return on invested capital (ROIC) of 2.2%. This is below average and may indicate limited pricing power.
FINE FOODS & PHARMACEUTICALS NT (FF-MI) does not currently pay a regular dividend.
FINE FOODS & PHARMACEUTICALS NT (FF-MI) operates in the Packaged Foods industry, within the Consumer Defensive sector.
FINE FOODS & PHARMACEUTICALS NT (FF-MI) reported annual revenue of $263 million in its most recent fiscal year, based on SEC EDGAR filings.
FINE FOODS & PHARMACEUTICALS NT (FF-MI) generated $13 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
FINE FOODS & PHARMACEUTICALS NT (FF-MI) has a debt-to-equity ratio of 0.40. This indicates a conservatively financed balance sheet.
FINE FOODS & PHARMACEUTICALS NT (FF-MI) reported earnings per share (EPS) of $34.57 in its most recent fiscal year.
The Ledger Terminal provides 4 years of financial data for FINE FOODS & PHARMACEUTICALS NT (FF-MI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.